Molecular Basis of the Toxigenic Vibrio cholerae O1 Serotype Switch from Ogawa to Inaba in Haiti.
Inaba
Ogawa
cholera
evolution
phylodynamics
serotype switch
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
14 02 2023
14 02 2023
Historique:
pubmed:
21
12
2022
medline:
17
2
2023
entrez:
20
12
2022
Statut:
ppublish
Résumé
Toxigenic Vibrio cholerae O1 serotype Ogawa was introduced involuntarily into Haiti in October 2010, and virtually all of the clinical strains isolated during the first 5 years of the epidemic were Ogawa. Inaba strains were identified intermittently prior to 2015, with diverse mutations resulting in a common phenotype. In 2015, the percentage of clinical infections due to the Inaba serotype began to rapidly increase, with Inaba supplanting Ogawa as the dominant serotype during the subsequent 4 years. We investigated the molecular basis of the serotype switch and confirmed that all Inaba strains had the same level of mRNA expression of the
Identifiants
pubmed: 36537825
doi: 10.1128/spectrum.03624-22
pmc: PMC9927444
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0362422Subventions
Organisme : NIAID NIH HHS
ID : R01 AI126357
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI128750
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI097405
Pays : United States
Références
mBio. 2020 Feb 11;11(1):
pubmed: 32047137
J Infect Dis. 2002 Jul 15;186(2):246-51
pubmed: 12134262
J Infect Dis. 2011 Sep 15;204(6):912-8
pubmed: 21849288
PLoS One. 2015 Apr 08;10(4):e0124098
pubmed: 25853552
PLoS One. 2014 Nov 14;9(11):e108521
pubmed: 25397871
Science. 2004 Jan 16;303(5656):327-32
pubmed: 14726583
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
PLoS Negl Trop Dis. 2016 Oct 7;10(10):e0005045
pubmed: 27716803
Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7897-7904
pubmed: 32229557
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2566-70
pubmed: 1372980
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Sci Rep. 2016 Oct 27;6:36115
pubmed: 27786291
Microbiol Immunol. 1993;37(4):281-8
pubmed: 7688846
Emerg Infect Dis. 2014 Mar;20(3):356-63
pubmed: 24571741
mBio. 2014 Dec 23;5(6):
pubmed: 25538191
Emerg Infect Dis. 2011 Apr;17(4):699-701
pubmed: 21470464
PLoS Comput Biol. 2007 Feb 16;3(2):e29
pubmed: 17305421
BMC Microbiol. 2013 Jul 26;13:173
pubmed: 23889924
PLoS Negl Trop Dis. 2016 Oct 5;10(10):e0005044
pubmed: 27706170
Proc Biol Sci. 2006 Nov 22;273(1603):2879-86
pubmed: 17015366
Clin Vaccine Immunol. 2012 Nov;19(11):1712-21
pubmed: 22993410
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
Scand J Infect Dis. 2010;42(1):48-56
pubmed: 19883159